2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol

C40H44N8O — CID 123495973

IUPAC2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol
SMILESCc1cc2c3c(n(C)c2c(CCc2cncc(C4CN(C)Cc5[nH]c6c(CC(O)c7ccncc7)cccc6c54)n2)n1)CCN1CCCC31
InChIInChI=1S/C40H44N8O/c1-24-18-29-38-34(13-17-48-16-5-8-35(38)48)47(3)40(29)31(43-24)10-9-27-20-42-21-32(44-27)30-22-46(2)23-33-37(30)28-7-4-6-26(39(28)45-33)19-36(49)25-11-14-41-15-12-25/h4,6-7,11-12,14-15,18,20-21,30,35-36,45,49H,5,8-10,13,16-17,19,22-23H2,1-3H3
InChIKeyCINUAPNYSQWFKB-UHFFFAOYSA-N
MW652.85 g/mol
LogP5.88
Rot. Bonds7

About 2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol

2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol (PubChem CID 123495973) has the molecular formula C40H44N8O and a molecular weight of 652.85 g/mol. Its IUPAC name is 2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol.

Molecular Properties

Compound Name2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol
PubChem CID123495973
Molecular FormulaC40H44N8O
Molecular Weight652.85 g/mol
Exact Mass652.36
IUPAC Name2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol
SMILESCc1cc2c3c(n(C)c2c(CCc2cncc(C4CN(C)Cc5[nH]c6c(CC(O)c7ccncc7)cccc6c54)n2)n1)CCN1CCCC31
InChIInChI=1S/C40H44N8O/c1-24-18-29-38-34(13-17-48-16-5-8-35(38)48)47(3)40(29)31(43-24)10-9-27-20-42-21-32(44-27)30-22-46(2)23-33-37(30)28-7-4-6-26(39(28)45-33)19-36(49)25-11-14-41-15-12-25/h4,6-7,11-12,14-15,18,20-21,30,35-36,45,49H,5,8-10,13,16-17,19,22-23H2,1-3H3
InChIKeyCINUAPNYSQWFKB-UHFFFAOYSA-N
XLogP5.88
TPSA98.99 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds7
Heavy Atoms49
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500652.85
LogP ≤ 55.88
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}

Analyze 2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol?
The IUPAC name of 2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol (CID 123495973) is 2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol.
What is the SMILES notation for 2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol?
The canonical SMILES for 2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol is Cc1cc2c3c(n(C)c2c(CCc2cncc(C4CN(C)Cc5[nH]c6c(CC(O)c7ccncc7)cccc6c54)n2)n1)CCN1CCCC31.
What is the InChIKey of 2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol?
The InChIKey is CINUAPNYSQWFKB-UHFFFAOYSA-N. The full InChI is InChI=1S/C40H44N8O/c1-24-18-29-38-34(13-17-48-16-5-8-35(38)48)47(3)40(29)31(43-24)10-9-27-20-42-21-32(44-27)30-22-46(2)23-33-37(30)28-7-4-6-26(39(28)45-33)19-36(49)25-11-14-41-15-12-25/h4,6-7,11-12,14-15,18,20-21,30,35-36,45,49H,5,8-10,13,16-17,19,22-23H2,1-3H3.
What are the key properties of 2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol?
2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol has a molecular weight of 652.85 g/mol, XLogP of 5.88, 7 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[6-[2-(10,14-dimethyl-6,10,13-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraen-12-yl)ethyl]pyrazin-2-yl]-2-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-8-yl]-1-pyridin-4-ylethanol is sourced from PubChem (CID 123495973), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).